Univest Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.6M Buy
33,820
+1,375
+4% +$1.4M 1.99% 12
2026
Q1
$29.8M Sell
32,445
-950
-3% -$963K 1.68% 14
2025
Q4
$35.9M Sell
33,395
-902
-3% -$862K 1.9% 12
2025
Q3
$26.2M Buy
34,297
+6,678
+24% +$4.97M 1.46% 14
2025
Q2
$21.5M Buy
27,619
+9,681
+54% +$7.52M 1.29% 16
2025
Q1
$14.8M Buy
17,938
+14,784
+469% +$12.3M 0.97% 21
2024
Q4
$2.43M Sell
3,154
-420
-12% -$348K 0.15% 105
2024
Q3
$3.17M Buy
3,574
+1,284
+56% +$1.15M 0.21% 87
2024
Q2
$2.07M Hold
2,290
0.58% 45
2024
Q1
$1.78M Hold
2,290
0.5% 45
2023
Q4
$1.33M Hold
2,290
0.39% 49
2023
Q3
$1.23M Sell
2,290
-200
-8% -$103K 0.41% 46
2023
Q2
$1.17M Hold
2,490
0.35% 47
2023
Q1
$855K Buy
2,490
+200
+9% +$67.5K 0.27% 51
2022
Q4
$838K Hold
2,290
0.26% 58
2022
Q3
$740K Hold
2,290
0.24% 62
2022
Q2
$743K Sell
2,290
-13
-0.6% -$3.9K 0.24% 54
2022
Q1
$660K Buy
2,303
+13
+0.6% +$3.35K 0.19% 56
2021
Q4
$633K Hold
2,290
0.16% 59
2021
Q3
$529K Hold
2,290
0.15% 61
2021
Q2
$526K Buy
2,290
+800
+54% +$161K 0.14% 63
2021
Q1
$278K Hold
1,490
0.08% 92
2020
Q4
$251K Hold
1,490
0.07% 97
2020
Q3
$221K Hold
1,490
0.07% 96
2020
Q2
$245K Hold
1,490
0.08% 92
2020
Q1
$206K Buy
+1,490
New +$205K 0.08% 104
2019
Q2
Sell
-1,652
Closed -$214K 111
2019
Q1
$214K Buy
+1,652
New +$201K 0.07% 108

Other funds holding LLY

Univest Financial's LLY Position: Q2 2026 in Review

Univest Financial increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $1.4M and bringing the position to 33,820 shares worth $40.6M. The position accounts for 1.99% of the portfolio, ranked #12.

Univest Financial first reported a position in LLY in Q1 2019 and has held it in 27 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Univest Financial held 33,820 shares of Eli Lilly worth $40.6M as of Q2 2026.
  • Univest Financial bought 1,375 Eli Lilly shares in Q2 2026, an estimated $1.4M.
  • Eli Lilly made up 1.99% of Univest Financial's portfolio in Q2 2026, its #12 holding.
  • Univest Financial first reported a position in Eli Lilly in Q1 2019 and has held it in 27 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Univest Financial's 13F filing for Q2 2026, filed 7 Aug 2026.